Correlations between Oxidative Stress and Blood Lipids Are Stronger in Men than Women

Oxidative stress is one cause of atherosclerosis that makes it a lifestyle-related disease. Oxidized low-density lipoprotein （OxLDL） was previously found to be related to oxidative stress, measured using the diacron-reactive oxygen metabolites （d-ROMs） test and showed a negative correlation between biological antioxidant potential （BAP） test results and triglycerides （TG）. In addition, large gender differences exist among vascular disorders caused by arteriosclerosis. However, such gender differences and their correlation with oxidative stress and blood lipids have not been clarified. In this study, gender differences in correlations between oxidative stress and blood lipids as factors in the development of atherosclerosis was addressed. Subjects were 149 individuals who underwent medical examinations conducted in Ashikaga Teishin Clinic in Tochigi, Japan （98 males and 51 females）. A strong positive correlation was observed between d-ROMs test results and OxLDL in men （R＝0.480, P<0.0001）, but no correlation was seen in women. A strong negative correlation between BAP test results and TG was also noted in men （R＝−0.571, P<0.0001）, and a moderate negative correlation was detected in women （R＝−0.344, P＝0.0133）. A positive correlation between d-ROMs tests and OxLDL was seen in women under 50 years of age （R＝0.399, P＝0.0393）, but this correlation was not present in women who were 50 years of age or older （R＝−0.00656, P＝0.976）. Correlations between oxidative stress and OxLDL and between antioxidant potential and TG in men were more prominent than in women. This finding suggests that decreasing oxidative stress in the blood to prevent atherosclerosis is more important for men

A Study on the Physical Sensations of Four Kinds of Trial Toothbrushes and Four Different Toothbrushing Methods

Using 65 students of the hygiene school attached to Matsumoto Dental College (35 first-year students, 30 second-year students) as subjects, we performed an investigation into the different physical sensations produced when using 4 trial toothbrushes and 4 different toothbrushing methods. The conclusions are as follows: 1. "Length of brush": There was a tendency to reply that the length of brush seemed slightly shorter when the students brushed with the Roll method, rather than the other three methods. 2. "Stiffness of filaments": There was a tendency to reply that the bristle was much harder when the students brushed with methods from Group B (Methods that primarily use the tip of the bristle) than with methods from Group A (Methods which use the side of the bristle). 3. "Tooth brush wear": A large percentage of students replied that the bristle was more durable when using methods from Group B rather than Group A. 4. "Physical sensation on tooth and gingiva": Brush M and the Open-tufted brush, both classified as "medium" stiffness, were preferred. 5. "Physical sensation of holding the handle": 80-90% of the students, regardless of the toothbrushing method employed, liked the handles of the brushes

(-)-Epigallocatechin-3-gallate Inhibits Differentiation and Matrix Metalloproteinases Expression in Osteoclasts

The osteoclast is a multinucleated giant cell differentiated from monocyte macrophages that has an important role in bone resorption. Several studies have reported a relationship between tea consumption and decreased risk of bone fracture. Matrix metalloproteinases (MMPs) play an important role in the degeneration of bone and cartilage matrix. Regulation of osteoclast activity is essential in the treatment of bone disease. Moreover, MMPs are associated with osteoclast formation and differentiation. We have reported previously that (-) -epigallocatechin-3-gallate (EGCG) inhibits MMP-2 and MMP-9 expression and activity. However, the effects of EGCG on osteoclasts and other MMPs are not clear. Therefore, in the present study we examined whether EGCG affects MMP expression, as well as osteoclast formation, differentiation and activity, in vitro. We used bone marrow cells from the femur and tibial bones of male ddY mice. Bone marrow cells were cultured in the presence of 1-100µM EGCG for 6 or 8 days. EGCG decreased the number of mature osteoclasts, as determined by tartrate-resistant acid phosphatase staining. Concentrations as low as 1µM EGCG clearly inhibited the differentiation of osteoclasts from bone marrow cells. EGCG also inhibited the number of osteoclasts with an actin-ring, as determined by rhodamine phalloidin staining, as well as osteoclast activity, as determined by the pit formation assay. Furthermore, EGCG concentration-dependently decreased MMP-9 and membrane type 1-MMP mRNA expression in mouse osteoclasts. However, EGCG had no changing on mRNA levels of tissue inhibitor of metalloprotease (TIMP)-1 and TIMP-3. Together, the results suggest that EGCG may be a suitable agent or lead compound for the development of treatments for bone resorption diseases associated with MMPs

Ventricular arrhythmia events in heart failure patients with cardiac resynchronization therapy with or without a defibrillator for primary prevention

Abstract Background It is uncertain whether cardiac resynchronization therapy with a defibrillator (CRT‐D) provides better survival benefits than a CRT‐pacemaker (CRT‐P) in heart failure patients with a reduced ejection fraction (≦35%, HFrEF) treated with contemporary HF therapy. Methods We retrospectively analyzed the ventricular arrhythmia (VAs; sustained ventricular tachycardia/fibrillation) events in HFrEF patients who underwent CRT without a prior history of VAs or aborted sudden cardiac death before the CRT implantation. Between January/2010 and December/2020, a CRT device was implanted in 79 HFrEF patients (mean age: 69 ± 12 years, male: 57, ischemic cardiomyopathy: 16). CRT‐D and CRT‐P devices were implanted in 50 and 29 patients, respectively, at each physician's discretion. CRT‐Ds were indicated in younger patients than were CRT‐Ps (66 ± 12 vs. 73 ± 12 years, p = 0.03), but the gender distribution did not differ (female, 24% [12 of 50] vs. 35% [10 of 29], p = 0.44). The VA events during a median follow‐up of 3.5‐years (interquartile range [IQR]:1.6–5.5) and their predictors were analyzed. Results VA events occurred in 9 patients with CRT‐Ds (18%) and one with a CRT‐P (3%, p = 0.08). The VA event rate was significantly lower in patients without a prior non‐sustained ventricular tachycardia (NSVT: ≥3 beats; rate, ≥120 bpm; lasting <30 s, HR 0.05; 95% CI 0.01–0.30; p < 0.01) and females (HR 0.11; 95% CI 0.01–0.93; p = 0.04). Of note, no female patients without a prior history of NSVT experienced VA events. Conclusion HFrEF CRT candidates without a prior history of NSVT and females may obtain less benefit from a primary preventive defibrillator indication

エチゼンクラゲの有効利用を目的とした降圧ペプチドの配列に関する研究（ポスター発表,青森から発信する保健・医療・福祉実践のためのエビデンス,2008年度青森県保健医療福祉研究発表会抄録）

publisher青

P-7. エチゼンクラゲの有効利用に関する研究 : 高濃度ペプチド溶液の調製法の開発(ポスター発表,保健・医療・福祉サービスの充実のために,2007年度青森県保健医療福祉研究発表会抄録)

publisher青森市国立情報学研究所の「学術雑誌公開支援事業」により電子化されまし